Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

429 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisolone combined with high-dose methotrexate plus intrathecal chemotherapy for newly diagnosed intravascular large B-cell lymphoma (PRIMEUR-IVL): a multicentre, single-arm, phase 2 trial.
Shimada K, Yamaguchi M, Atsuta Y, Matsue K, Sato K, Kusumoto S, Nagai H, Takizawa J, Fukuhara N, Nagafuji K, Miyazaki K, Ohtsuka E, Okamoto M, Sugita Y, Uchida T, Kayukawa S, Wake A, Ennishi D, Kondo Y, Izumi T, Kin Y, Tsukasaki K, Hashimoto D, Yuge M, Yanagisawa A, Kuwatsuka Y, Shimada S, Masaki Y, Niitsu N, Kiyoi H, Suzuki R, Tokunaga T, Nakamura S, Kinoshita T. Shimada K, et al. Among authors: yanagisawa a. Lancet Oncol. 2020 Apr;21(4):593-602. doi: 10.1016/S1470-2045(20)30059-0. Epub 2020 Mar 11. Lancet Oncol. 2020. PMID: 32171071 Clinical Trial.
Prospective Phase 2 Study of Umbilical Cord Blood Transplantation in Adult Acute Leukemia and Myelodysplastic Syndrome.
Terakura S, Nishida T, Sawa M, Kato T, Miyao K, Ozawa Y, Kohno A, Onishi Y, Fukuhara N, Kasai M, Fujii N, Yokoyama H, Iida H, Kanemura N, Fujieda A, Ago H, Tsutsumi Y, Nakamura F, Yago K, Moriuchi Y, Ota S, Ohashi H, Yanagisawa A, Suzuki R, Kuwatsuka Y, Atsuta Y, Miyamura K, Murata M; Nagoya Blood and Marrow Transplantation Group. Terakura S, et al. Among authors: yanagisawa a. Biol Blood Marrow Transplant. 2020 Jan;26(1):139-144. doi: 10.1016/j.bbmt.2019.09.021. Epub 2019 Sep 20. Biol Blood Marrow Transplant. 2020. PMID: 31546004 Free article. Clinical Trial.
Prospective evaluation of alternative donor from unrelated donor and cord blood in adult acute leukemia and myelodysplastic syndrome.
Terakura S, Nishida T, Sawa M, Kato T, Miyao K, Ozawa Y, Goto T, Kohno A, Ozeki K, Onishi Y, Fukuhara N, Fujii N, Yokoyama H, Kasai M, Iida H, Kanemura N, Endo T, Ago H, Onizuka M, Iyama S, Nawa Y, Nakamae M, Nagata Y, Kurahashi S, Tomiya Y, Yanagisawa A, Suzuki R, Kuwatsuka Y, Atsuta Y, Miyamura K, Murata M; Nagoya Blood and Marrow Transplantation Group. Terakura S, et al. Among authors: yanagisawa a. Bone Marrow Transplant. 2020 Jul;55(7):1399-1409. doi: 10.1038/s41409-020-0859-8. Epub 2020 Mar 16. Bone Marrow Transplant. 2020. PMID: 32203259
Resolved versus Active Chronic Graft-versus-Host Disease: Impact on Post-Transplantation Quality of Life.
Kurosawa S, Yamaguchi T, Oshima K, Yanagisawa A, Fukuda T, Kanamori H, Mori T, Takahashi S, Kondo T, Kohno A, Miyamura K, Umemoto Y, Teshima T, Taniguchi S, Yamashita T, Inamoto Y, Kanda Y, Okamoto S, Atsuta Y. Kurosawa S, et al. Among authors: yanagisawa a. Biol Blood Marrow Transplant. 2019 Sep;25(9):1851-1858. doi: 10.1016/j.bbmt.2019.05.016. Epub 2019 May 24. Biol Blood Marrow Transplant. 2019. PMID: 31129353 Free article. Clinical Trial.
Quality of Life after Allogeneic Hematopoietic Cell Transplantation According to Affected Organ and Severity of Chronic Graft-versus-Host Disease.
Kurosawa S, Oshima K, Yamaguchi T, Yanagisawa A, Fukuda T, Kanamori H, Mori T, Takahashi S, Kondo T, Kohno A, Miyamura K, Umemoto Y, Teshima T, Taniguchi S, Yamashita T, Inamoto Y, Kanda Y, Okamoto S, Atsuta Y. Kurosawa S, et al. Among authors: yanagisawa a. Biol Blood Marrow Transplant. 2017 Oct;23(10):1749-1758. doi: 10.1016/j.bbmt.2017.06.011. Epub 2017 Jun 29. Biol Blood Marrow Transplant. 2017. PMID: 28669922 Free article.
Employment status was highly associated with quality of life after allogeneic hematopoietic cell transplantation, and the association may differ according to patient age and graft-versus-host disease status: analysis of a nationwide QOL survey.
Kurosawa S, Yamaguchi T, Oshima K, Yanagisawa A, Fukuda T, Kanamori H, Mori T, Takahashi S, Kondo T, Fujisawa S, Onishi Y, Yano S, Onizuka M, Kanda Y, Mizuno I, Taniguchi S, Yamashita T, Inamoto Y, Okamoto S, Atsuta Y. Kurosawa S, et al. Among authors: yanagisawa a. Bone Marrow Transplant. 2019 Apr;54(4):611-615. doi: 10.1038/s41409-018-0343-x. Epub 2018 Oct 4. Bone Marrow Transplant. 2019. PMID: 30287939 No abstract available.
[Hematopoietic cell transplantation in Japan: nationwide survey 2013].
Kurata M, Yanagisawa A, Atsuta Y, Sakamaki H, Kato K, Ichinohe T, Tanaka J, Hirokawa M, Adachi S, Inoue M, Kikuchi A, Yabe H, Kawa K, Sawada A, Mori S, Morishima Y, Kato S, Nagamura T, Matsumoto K, Suzuki R, Nakao S, Takanashi M, Kodera Y, Okamoto S. Kurata M, et al. Among authors: yanagisawa a. Rinsho Ketsueki. 2014 Dec;55(12):2381-99. doi: 10.11406/rinketsu.55.2381. Rinsho Ketsueki. 2014. PMID: 25744039 Review. Japanese. No abstract available.
429 results